Mytrus, a stealth-mode provider of clinical trials for pharmaceutical customers, has secured $1 million of a $3 million funding round, according to a regulatory filing. No investor information was disclosed by the Mill Valley, Calif.-based company.
Mytrus, a stealth-mode provider of clinical trials for pharmaceutical customers, has secured $1 million of a $3 million funding round, according to a regulatory filing. No investor information was disclosed by the Mill Valley, Calif.-based company.